+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Anti-tolA antibody in non-A, non-B chronic liver disease

Anti-tolA antibody in non-A, non-B chronic liver disease

Fukuoka Igaku Zasshi 83(10): 367-376

We constructed a cDNA library against the plasma obtained from the patient with acute exacerbation of non-A, non-B liver cirrhosis, and immunoscreened this library with the sera obtained from the patients with non-A, non-B chronic liver disease. One positive clones lambda-22C containing about 1.2 kb cDnA insert was isolated from 10-6 clones. Nucleotide sequence determination and subsequent homology search revealed its identity to the tolA gene of Escherichia coli. Anti-tolA antibody was detected in 54.5% of the patients with NANB chronic liver disease whose sera was negative for antibody to hepatitis C virus (anti-C100). In contrast, anti-tolA was detected only of 14.6% patients with anti-C100 positive NANB chronic liver disease, 10.5% with hepatitis B surface antigen-positive chronic liver disease, 7.7% with alcoholic liver disease and 4.2% in normal control, and non positive case in acute hepatitis of etiology and in primary biliary cirrhosis. However, antibody to the core protein of hepatitis C virus (anti-JCC) was detected 50% of the patients whose sera were negative for anti-C100 but positive for anti-tolA. Recently, it has been reported that hepatitis C virus is rich in mutations and has some variants. These results indicated the presence of a common epitope between the tolA protein and some agent related to non-A, non-B hepatitis, especially to anti-C100 negative non-A, non-B hepatitis such as variants of hepatitis C virus which have mutations in C100 coded region.

(PDF 0-2 workdays service: $29.90)

Accession: 009770189

Download citation: RISBibTeXText

PMID: 1281459

Related references

Prevalence of anti-HCV antibody in family members of anti-HCV-positive patients with acute and chronic liver disease. Southeast Asian Journal of Tropical Medicine and Public Health 23(1): 12-16, 1992

Specificities and clinical significance of anti-cytoskeleton antibodies in anti-smooth muscle antibody-positive patients with chronic liver disease C. Acta Medica Okayama 48(3): 143-149, 1994

Anti-neutrophil cytoplasmic antibody in chronic liver disease. Gastroenterology 108(4 SUPPL ): A1114, 1995

Prevalence of anti hcv antibody in chronic liver disease in czechoslovakia. Journal of Hepatology 11(SUPPL 2): S114, 1990

Anti c 100 antibody of igm isotype in hepatitis c virus associated chronic liver disease. Gentilini, P And M U Dianzani (Ed ) International Congress Series, No 995 Experimental And Clinical Hepatology; Annual Meeting Of The Italian National Programme on Liver Cirrhosis And Viral Hepatitis, Pisa, Italy, January 9-11, 1992 Xvii+287p Elsevier Science Publishers B V : Amsterdam, Netherlands; (Dist in The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York, Usa) Illus 181-188, 1991

Prevalence and role of antibody to virus c anti vhc in non b non alcoholic chronic liver disease. Journal of Hepatology 13(SUPPL 2): S94, 1991

Detection of anti-double and anti-single stranded DNA antibodies in chronic liver disease: significance of anti-double stranded DNA antibody in autoimmune hepatitis. Journal of Gastroenterology 29(2): 152-158, 1994

Serum markers of hepatitis B virus and anti-delta antibody in chronic liver disease. Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 21(4): 387-398, 1985

Prevalence and role of antibody to virus c anti hcv in non b chronic liver disease in alcohol abuses. Journal of Hepatology 13(SUPPL 2): S94, 1991

Prevalence of anti-GOR antibody production in hepatitis C virus RNA-positive non-A, non-B chronic liver disease. Dokkyo Journal of Medical Sciences 19(2): 87-93, 1992

Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease. Acta Medica Academiae Scientiarum Hungaricae 39(3-4): 161-168, 1982

Serum hydroxy proline protein and anti collagen antibody in patients with chronic liver disease. Gastroenterology 79(5 PART 2): 1126, 1980

Comparison of different cell substrates for the detection of anti actin microfilaments antibody in chronic liver disease. Journal of Hepatology (SUPPL 2): S352, 1985

High prevalence of anti-hepatitis delta virus antibody in chronic liver disease in Somalia. Transactions of the Royal Society of Tropical Medicine and Hygiene 85(4): 541-542, 1991